Where β2-adrenergic receptor autoantibodies is reported
Also listed as: Anti-β2AR; GPCR autoAbs — ME/CFS overlap
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Gulf War Illness | ↑ elevated | healthy Gulf War veteran controls | Dysautonomia | Gean et al. 2021 |
| ME/CFS | ↑ elevated | healthy controls | Dysautonomia, POTS | Maksoud et al. 2023 |
Frequently asked questions
In which conditions is β2-adrenergic receptor autoantibodies altered?
In the OSMF atlas β2-adrenergic receptor autoantibodies is reported in Gulf War Illness, ME/CFS. It is elevated in 2 across 2 entries.
Does β2-adrenergic receptor autoantibodies point to one specific diagnosis?
No. Because β2-adrenergic receptor autoantibodies changes in several conditions (Gulf War Illness, ME/CFS), an abnormal result cannot identify which condition, if any, is present. It must be interpreted with symptoms, history and other tests.
Is there a standard clinical test for β2-adrenergic receptor autoantibodies?
The atlas entries for β2-adrenergic receptor autoantibodies do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal β2-adrenergic receptor autoantibodies result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.